Fundraising FoxResolve Therapeutics
3 known investors
Find your way into Resolve Therapeutics
Sign up to see every warm intro you have to Resolve Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Resolve Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.
Founders & leadership
JP
James Posada, Ph.D.FounderJames Posada holds a Ph.D. and founded Resolve Therapeutics, a biotechnology company developing drugs for autoimmune diseases and critical care medicine. He has negotiated partnering transactions with pharmaceutical companies for biotech clients.
Investors · 3
New Science Ventureslisted by New Science VenturesGreenwich · $2M – $8M
How we know: New Science Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
Easton CapitalreportedNew York · $10M – $20M
How we know: funding news · Not right? Tell us
WRF CapitalreportedSeattle · $100K – $2M
How we know: funding news · Not right? Tell us
Related companies · 4
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
RisetherapeuticsRise Therapeutics develops oral immunotherapies, called Oral Immune BioModulators, using a synthetic biology-based drug design approach to treat autoimmune diseases and cancer. The company combines immunology research with in-house clinical GMP manufacturing and regulatory expertise to advance its pipeline through clinical validation.
SoluSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Applied TherapeuticsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.
Companies working in the same space as Resolve Therapeutics.
Frequently asked questions
- What does Resolve Therapeutics do?
- Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.
- Who founded Resolve Therapeutics?
- Resolve Therapeutics was founded by James Posada, Ph.D..
- Who are Resolve Therapeutics's investors?
- Resolve Therapeutics's investors include New Science Ventures, Easton Capital, WRF Capital.